[AMRX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 218.06%
YoY- 109.86%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 701,780 599,046 559,355 535,075 464,662 404,642 413,787 9.19%
PBT 20,405 29,660 -232,731 34,824 -21,758 -56,227 -262,506 -
Tax 3,618 -23 7,350 2,648 2,186 -5,701 -12,416 -
NP 5,994 11,917 -120,808 14,532 -11,996 -16,902 -219,445 -
Tax Rate -17.73% 0.08% - -7.60% - - - -
Total Cost 695,786 587,129 680,163 520,543 476,658 421,544 633,232 1.58%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.85 1.99 -21.60 2.72 -2.58 -4.18 -53.03 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.02 0.08 -0.80 0.10 -0.08 -0.13 -1.73 -
EPS Diluted 0.02 0.08 -0.80 0.10 -0.08 -0.13 -1.73 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.